Maze Therapeutics, Inc. MAZE
32.43 USD +1.23 (+3.94%)
Regular-session close
32.46 +0.03 +0.09%
After hours · Nov 19, 7:43 PM ET
30.69 Day range 32.74
21.95 52-week range 53.65
- YTD
- -21.72%
- 1 year
- -8.75%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 142.90M | 109.91M | 98.55M | 111.03M | |
| 108.45M | 83.50M | 73.94M | 88.19M | |
| 34.45M | 26.42M | 24.61M | 22.83M | |
| -142.90M | 57.59M | -98.55M | -111.03M | |
| -131.12M | 3.40M | -100.42M | -114.94M | |
| -131.12M | 3.40M | -100.42M | -114.94M | |
| -131.12M | 3.40M | -100.42M | -114.94M | |
| -131.12M | 52.23M | -100.42M | -114.94M | |
| -3.05 | 1.42 | -43.89 | -5.93 | |
| -3.05 | 1.42 | -43.89 | -5.93 | |
| -3.05 | 1.25 | -43.89 | -5.93 | |
| -131.12M | 4.58M | -100.42M | -114.94M | |
| -131.12M | 4.58M | -100.42M | -114.94M | |
| 42.98M | 2.40M | 2.29M | 19.38M | |
| 42.98M | 2.73M | 2.29M | 19.38M |
